McKesson acquires Precision Medicine Group for $2.25 billion
Drug distributor McKesson agreed to buy privately held Precision Medicine Group in a $2.25 billion deal, continuing its multi-year strategy to strengthen higher-growth clinical research capabilities.
2 sourcesPrecision medicine
00